Paclitaxel Exposure and Dosage of Drug-coated Devices for the Treatment of Femoropopliteal Peripheral Artery Disease

The role of paclitaxel in the treatment of femoropopliteal peripheral arterial disease is currently ambiguous. A summary-level meta-analysis of randomised trials published in 2018 demonstrated that paclitaxel-coated devices were associated with an increased all-cause mortality in those who underwent...

Full description

Saved in:
Bibliographic Details
Main Authors: Ceazón T Edwards, Peter A Schneider, Cindy Huynh
Format: article
Language:EN
Published: Radcliffe Medical Media 2021
Subjects:
Online Access:https://doaj.org/article/a60b7e2b755e4b9aa004805cc787644a
Tags: Add Tag
No Tags, Be the first to tag this record!